Publications by authors named "Jeff Cramer"

Claim this Profile
A
Affinity Capture Elution Coupled with Cell-based Cyclic Adenosine Monophosphate Assay as a Platform Method for Detection of Neutralizing Antibodies to Incretin Molecules.
Nichole A Reynolds, Yan Q Chen, Richard E Higgs, Boris Calderon, Jeff W Cramer

AAPS J· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Monovalent Fab Affinity-Capture and Elution Bridging Immunoassay Overcomes Rheumatoid Factor Interference while Accurately Detecting Antidrug Antibodies.
Boris Calderon, Nichole A Reynolds, Craig A Swearingen, Quincy L Carter, Nicoletta Bivi, Jeff W Cramer

J Appl Lab Med· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure-Based Design of Active-Site-Directed, Highly Potent, Selective, and Orally Bioavailable Low-Molecular-Weight Protein Tyrosine Phosphatase Inhibitors.
Rongjun He, Jifeng Wang, Zhi-Hong Yu, Julie S Moyers, M Dodson Michael, Jeff W Cramer

J Med Chem· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The method history report: an adaptable tool for communicating immunogenicity assay development and validation.
Kristin Hollister, Huy T Nguyen, Jessie L Bishop, Jeff W Cramer, Nicoletta Bivi

Bioanalysis· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Digital Image Correlation of Forescatter Detector Images for Simultaneous Strain and Orientation Mapping.
Derrik Adams, Shamoon Irfan, Jeff Cramer, Michael P Miles, Eric R Homer

Microsc Microanal· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and Pharmacological Characterization of 2-(2,6-Dichlorophenyl)-1-((1,3)-5-(3-hydroxy-3-methylbutyl)-3-(hydroxymethyl)-1-methyl-3,4-dihydroisoquinolin-2(1)-yl)ethan-1-one (LY3154207), a Potent, Subtype Selective, and Orally Available Positive Allosteric Modulator of the Human Dopamine D1 Receptor.
Junliang Hao, James P Beck, John M Schaus, Joseph H Krushinski, Qi Chen, Jeff W Cramer

J Med Chem· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and biological evaluation of aryl-oxadiazoles as inhibitors of Mycobacterium tuberculosis.
Maria Angeles Martinez-Grau, Isabel C Gonzalez Valcarcel, Julie V Early, Richard Klaus Gessner, Candice Soares de Melo, Jeff W Cramer

Bioorg Med Chem Lett· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Difference in the Pharmacokinetics and Hepatic Metabolism of Antidiabetic Drugs in Zucker Diabetic Fatty and Sprague-Dawley Rats.
Xin Zhou, Luc R A Rougée, David W Bedwell, Jeff W Cramer, Michael A Mohutsky

Drug Metab Dispos· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
5
5-HT1A receptor antagonists reduce food intake and body weight by reducing total meals with no conditioned taste aversion.
M Joelle Dill, Janice Shaw, Jeff Cramer, Dana K Sindelar

Pharmacol Biochem Behav· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduction of nonspecific protein binding on surface plasmon resonance biosensors.
Jean-Francois Masson, Tina M Battaglia, Jeff Cramer, Stephen Beaudoin, Michael Sierks

Anal Bioanal Chem· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recent advancements in chemometrics for smart sensors.
Frank Vogt, Brian Dable, Jeff Cramer, Karl Booksh

Analyst· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis